News and Reports
-
Successful sale of BRAHMS in an all-cash transaction to Thermo Fisher Scientific: Net profit for HBM advised antities of EUR 134.2 million, or 21.6 times the invested equity
3 September 2009Download -
PTC Therapeutics announces achievement of major milestone in Schering- Plough Hepatitis C collaboration
10 August 2009Download -
Zosana Pharma, Inc. secures $30 million in new round of financing
7 July 2009Download -
Brahms - New cardiac marker copeptin accelerates diagnosis of acute myocardial infarction (AMI)
2 July 2009Download -
Sloning BioTechnology and Henkel to cooperate in enzyme development
30 June 2009Download -
Brahms - Cezanne and Lumiphore announces partnership for diagnostic tests
22 June 2009Download -
Vivacta raises $4.5 million to commercialise piezofilm technology
16 June 2009Download -
MiCardia announces first U.S. implant
16 June 2009Download -
Devax receives IDE approval to commence bifurcation stent trial
29 May 2009Download -
mtm laboratories and MetaSystems agree on partnership to develop Automated CINtec Cytology Imaging System
26 May 2009Download -
Brahms - for the first time, a new Biomarker test enables detection of Alzheimer's dementia in blood
15 May 2009Download -
Diagnostics company BRAHMS presents positive results for 2008
13 May 2009Download -
Merck KGaA, global partner of Newron, initiates second phase III trial of safinamide in advanced Parkinson's disease
7 May 2009Download -
Anthera's varespladib meets primary endpoint in phase 2 FRANCIS trial for the treatment of acute coronary syndrome
6 May 2009Download -
Ophthotech's positive results for their Novel Therapy for Wet AMD
4 May 2009Download -
Lux reports first oral drug for uveitis which reduces both inflammation and recurrence rate in potientially blinding eye disease
4 May 2009Download -
Mpex's new CBO Mark Wiggins joins from Biogen Idec
20 April 2009Download -
Lux Biosciences reports positive results from LUMINATE Phase 3 program of LX211 (LUVENIQ) in Uveitis
26 March 2009Download -
ESBATech ESBA105 demonstrates efficacy in the back of the eye to inhabit neovascularization
24 March 2009Download -
Anthera's IMPACTS trial demonstrates favorable interim results in preventing sickle cell complication
24 March 2009Download -
Nereus Pharmaceuticals initiates randomized phase 2 clinical trial in non-small cell lung cancer
23 March 2009Download -
MiCardia announces worlds' first dynamic heart valve repair on a beating heart
17 February 2009Download -
Newron announces improved motor function in phase III Parkinson's trial of Safinamade
3 February 2009Download -
Biomarin's Kuvan receives marketing approval in the EU
9 December 2008Download -
Broncus Technologies Secures 38$ Million in fundind round led by Ares Life Sciences
4 December 2008Download